© 2022 All rights reserved.
AI Medical Technology AI Medical Technology
  • Home
  • Dermalyser
  • About
  • Research
  • News & Blog
Contact Us
AI Medical Technology
Contact Us

News, Events & Blog

AI Medical Technology wins Techarenan Challenge 2023 Business Award

inNews

🏆🥇🎉 We are immensely proud and thrilled to have won the Techarenan Challenge 2023 Business Award – and what a memorable event!

This recognition is truly a testament to the relentless efforts of our exceptional, multidisciplinary team, whose contributions have all been integral in developing Dermalyser – our user-friendly, AI-based decision support tool that is revolutionizing the speed and accuracy of skin cancer diagnosis.

Our CEO, Christoffer Ekström, comments ‘winning the Techarenan Challenge Business Award is incredible and also affirmation of our commitment to a market approach that prioritizes accuracy and patient wellbeing, evidenced by our dedicated pursuit of responsible clinical validation.’

We’d like to extend our gratitude to the panel of judges and our congratulations to the winners in the other categories! 👏🙏🌟

AMT Image Step 2.7
  • AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer
    Previous PostAI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer
  • Next PostHow Often Should You Get Checked for Skin Cancer?
    AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer

Related Posts

AI Medical Technology CEO Christoffer Ekstrom Interviewed In Pharma Intelligence
News

AI Medical Technology CEO Christoffer Ekstrom Interviewed In Pharma Intelligence

AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer
News Press Releases

AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer

AI Medical Technology nets SEK10.8 million to accelerate Dermalyser AI-driven diagnostic support tool for skin cancer
News

AI Medical Technology nets SEK10.8 million to accelerate Dermalyser AI-driven diagnostic support tool for skin cancer

AI Medical Technology logo colour

Website Privacy Policy

Contact Us

Dermalyser

BSI

+46 721748339
Stockholm, Sweden

© 2022 All rights reserved

Copy